-
GlobalData：阿斯利康的 Lynparza 将在 2027 年以 40 亿美元的销售额主导 PARP 抑制剂市场
- 来源: https://www.expresspharma.in/astrazenecas-lynparza-to-dominate-parp-inhibitors-market-with-4-bn-in-sales-by-2027-globaldata/
- 207
- 2024-05-04
-
BD 印度静脉峰会重点关注改善患者护理的最佳实践
- 来源: https://www.healthpartners.com/ucm/groups/public/@hp/@public/documents/documents/entry_191059.pdf
- 200
- 2024-05-04
-
Senseonics获得美国FDA批准将CGM植入物与胰岛素泵配对
- 来源: https://www.medtechdive.com/news/senseonics-fda-clearance-integrated-cgm/714804/
- 271
- 2024-05-03
-
阿西莫夫慢病毒产量提高10倍，推出新的稳定细胞系开发服务
- 来源: https://www.news-medical.net/news/20240430/Asimov-achieves-10x-improvement-in-lentiviral-production-launches-new-stable-cell-line-development-service.aspx
- 198
- 2024-05-03
-
深势科技 DevDay 2024 展示大型科学模型并宣布开放科学计划
- 来源: https://en.prnasia.com/releases/global/dp-technology-devday-2024-showcases-large-science-models-and-announces-open-science-initiative-445188.shtml
- 183
- 2024-05-03
-
FDA 批准 X4 制药公司的 WHIM 综合征药物
- 来源: https://www.pharmaceutical-technology.com/news/fda-x4-syndrome-drug/?cf-view
- 177
- 2024-05-03
-
Lupin 的奥兰加巴德制造工厂获得美国 FDA 颁发的 EIR
- 来源: https://www.lupin.com/lupin-receives-eir-from-us-fda-for-its-aurangabad-manufacturing-facility/
- 156
- 2024-05-03
-
康哲药业Zydus Desidusat片新药申请在中国获受理
- 来源: https://www.biospace.com/article/releases/china-medical-system-new-drug-application-of-desidustat-tablets-accepted-in-china/
- 360
- 2024-05-03
-
武田、Astellas和三井住友成立合资公司，将日本创新从“死亡谷”中拯救出来
- 来源: https://medcitynews.com/author/fvinluan/
- 202
- 2024-05-03
-
